These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9019855)

  • 1. [Negative reports on oral contraceptives--increased number of interrupted pregnancies].
    Nilsen ST; Iversen OE
    Tidsskr Nor Laegeforen; 1996 Nov; 116(29):3486-8. PubMed ID: 9019855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sale of oral contraceptives, births and abortions prior to and after the "Marvelon issue"].
    Skjeldestad FE
    Tidsskr Nor Laegeforen; 2000 Jan; 120(3):339-44. PubMed ID: 10827525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased number of induced abortions in Norway after media coverage of adverse vascular events from the use of third-generation oral contraceptives.
    Skjeldestad FE
    Contraception; 1997 Jan; 55(1):11-4. PubMed ID: 9013055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alarming increase in the number of abortions. Does fear of thrombosis limit the use of oral contraceptives?].
    Milsom I; Odlind V; Hedberg C; Lidegaard O
    Lakartidningen; 1997 Dec; 94(50):4731-2, 4735-6. PubMed ID: 9445952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study.
    Lidegaard O
    Acta Obstet Gynecol Scand; 1997 Mar; 76(3):252-60. PubMed ID: 9093141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptive use and venous thromboembolism: a consideration of the impact of bias and confounding factors on epidemiological studies.
    Rekers H; Norpoth T; Michaels MA
    Eur J Contracept Reprod Health Care; 1996; 1(1):21-30. PubMed ID: 9678134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Third generation oral contraceptives and heritable thrombophilia as risk factors of non-fatal venous thromboembolism.
    Andersen BS; Olsen J; Nielsen GL; Steffensen FH; Sørensen HT; Baech J; Gregersen H
    Thromb Haemost; 1998 Jan; 79(1):28-31. PubMed ID: 9459317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reporting of adverse drug reactions to the Norwegian Drug Control Agency].
    Skjeldestad FE; Amundsen T; Høibraaten E
    Tidsskr Nor Laegeforen; 2000 Jan; 120(3):336-8. PubMed ID: 10827524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
    Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives and liver cancer. Results of the Multicentre International Liver Tumor Study (MILTS).
    Contraception; 1997 Nov; 56(5):275-84. PubMed ID: 9437555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The truth about oral contraceptives and venous thromboembolism.
    Shulman LP; Goldzieher JW
    J Reprod Med; 2003 Nov; 48(11 Suppl):930-8. PubMed ID: 14686030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
    Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
    Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Contraceptive agents and risk of thrombosis].
    Maurer-Major E; Keller PJ
    Praxis (Bern 1994); 1997 Oct; 86(40):1543-8. PubMed ID: 9417570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The recent pill scare and number of legal abortions in Norway.
    Iversen OE; Nilsen ST
    Acta Obstet Gynecol Scand; 1996 Aug; 75(7):690-1. PubMed ID: 8822671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study.
    Hannaford PC; Kay CR
    Br J Gen Pract; 1998 Oct; 48(435):1657-62. PubMed ID: 10071398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contraception and abortions].
    Nesheim BI
    Tidsskr Nor Laegeforen; 1999 Jan; 119(2):177. PubMed ID: 10081344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy.
    Douketis JD; Ginsberg JS; Holbrook A; Crowther M; Duku EK; Burrows RF
    Arch Intern Med; 1997 Jul; 157(14):1522-30. PubMed ID: 9236553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abortion in the framework of family planning in Estonia.
    Karro H
    Acta Obstet Gynecol Scand Suppl; 1997; 164():46-50. PubMed ID: 9225637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraception: where do we stand?
    Diczfalusy E
    Contemp Rev Obstet Gynaecol; 1992 Jul; 4(3):148-53. PubMed ID: 12287020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.